GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » IMGT Corp Ltd (XKRX:456570) » Definitions » Repurchase of Stock

IMGT (XKRX:456570) Repurchase of Stock : ₩0.00 Mil (TTM As of Dec. 2024)


View and export this data going back to 2023. Start your Free Trial

What is IMGT Repurchase of Stock?

IMGT's Repurchase of Stock for the six months ended in Dec. 2024 was ₩0.00 Mil.

IMGT's Repurchase of Stock for the trailing twelve months (TTM) ended in Dec. 2024 was ₩0.00 Mil.


IMGT Repurchase of Stock Historical Data

The historical data trend for IMGT's Repurchase of Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IMGT Repurchase of Stock Chart

IMGT Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24
Repurchase of Stock
- - - - -

IMGT Semi-Annual Data
Dec20 Dec21 Dec22 Dec23 Dec24
Repurchase of Stock - - - - -

IMGT Repurchase of Stock Calculation

A company may raise cash from issuing new shares. It can also use cash to buy back shares. Repurchase of Stock represents the cash outflow to reacquire common stock during the period.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Repurchase of Stock for the trailing twelve months (TTM) ended in Dec. 2024 was ₩0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


IMGT Repurchase of Stock Related Terms

Thank you for viewing the detailed overview of IMGT's Repurchase of Stock provided by GuruFocus.com. Please click on the following links to see related term pages.


IMGT Business Description

Traded in Other Exchanges
N/A
Address
172 Dolma-ro,, 408, Healthcare Innovation Park, Bundang-gu, Gyeonggi-do, Seongnam-si, KOR, 13605
IMGT Corp Ltd develops a focused ultrasound-based drug delivery platform for intractable diseases. It is developing nanomedicines and focused ultrasound medical devices that respond to focused ultrasound. The firm has two pipeline products IMD20 and IMP101. IMD20 is a FUS device developed for chronic pain as a product with reduced size and output from IMD10 developed for cancer treatment. IMP101 is a nanoparticle used for hepatocarcinoma embolization.

IMGT Headlines

No Headlines